NEW YORK, Oct. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PROG, FAMI, RRD, SOFI, and VYGR.

InvestorsObserver (PRNewsfoto/InvestorsObserver)

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  • PROG: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=PROG&prnumber=101220217
  • FAMI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=FAMI&prnumber=101220217
  • RRD: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=RRD&prnumber=101220217
  • SOFI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SOFI&prnumber=101220217
  • VYGR: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=VYGR&prnumber=101220217

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-progenity-farmmi-rr-donnelley--sons-sofi-technologies-or-voyager-therapeutics-301398209.html

SOURCE InvestorsObserver